Condition
Phobia, Specific
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07024758Not ApplicableRecruiting
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
NCT02533310Not ApplicableCompletedPrimary
Virtual Reality Immersive Method for Spider (Phobia) Exposure Therapy (VIMSE)
NCT02789813Phase 2CompletedPrimary
Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.
NCT02622087Not ApplicableCompletedPrimary
The Impact of Sex Hormones on One-session Treatment for Spider Phobia in Women
Showing all 4 trials